Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Diatrizoate sodium
Drug ID BADD_D00646
Description A commonly used x-ray contrast medium. As diatrizoate meglumine and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.
Indications and Usage Used, alone or in combination, for a wide variety of diagnostic imaging methods, including angiography, urography, cholangiography, computed tomography, hysterosalpingography, and retrograde pyelography. It can be used for imaging the gastrointestinal tract in patients allergic to barium.
Marketing Status Discontinued
ATC Code V08AA01
DrugBank ID DB00271
KEGG ID D01013
MeSH ID D003973
PubChem ID 23672589
TTD Drug ID D0T9DT
NDC Product Code 65392-1701; 69037-0052; 76055-0014; 66577-032
Synonyms Diatrizoate | Benzoic acid, 3,5-bis(acetylamino)-2,4,6-triiodo- | Hypaque | Diatrizoic Acid | Urothrast | Urotrast | Urogranoic Acid | Sodium Diatrizoate | Diatrizoate, Sodium | Diatrizoate Sodium | Sodium-Magnesium Diatrizoate | Diatrizoate, Sodium-Magnesium | Amidotrezoate | Amidotrizoate | Hypaque 50
Chemical Information
Molecular Formula C11H8I3N2NaO4
CAS Registry Number 737-31-5
SMILES CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nausea07.01.07.001--
Necrosis08.03.03.001; 24.04.02.006--Not Available
Nephrotic syndrome20.05.01.002--
Pain08.01.08.004--
Paraesthesia17.02.06.005--
Paralysis17.01.04.004--Not Available
Parotid gland enlargement07.06.03.001--Not Available
Petechiae23.06.01.003; 01.01.03.002; 24.07.06.004--Not Available
Pruritus23.03.12.001--
Pulmonary oedema22.01.03.003; 02.05.02.003--
Renal failure20.01.03.005--Not Available
Rhinitis22.07.03.006; 11.01.13.004--
Seizure17.12.03.001--
Sinus bradycardia02.03.03.009--
Submaxillary gland enlargement07.06.03.003--Not Available
Tachycardia02.03.02.007--Not Available
Thrombocytopenia01.08.01.002--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Ventricular fibrillation02.03.04.008--
Vomiting07.01.07.003--
Haemodynamic instability24.03.02.006--Not Available
Cerebral haematoma17.08.01.014; 24.07.04.006--Not Available
Skin oedema23.06.04.001--Not Available
Vasodilation procedure25.03.01.001--Not Available
Vessel puncture site swelling12.07.04.007; 08.02.04.006--Not Available
The 2th Page    First    Pre   2    Total 2 Pages